SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Arthur Ashe Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientArthur Ashe
Date of birth1943-07-10
IdentifiersMRN HR-ML013-SYN-TD; SSN (made up) 000-13-6620
Document date2026-11-01
AuthorVivian Tolliver, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care for HIV after a recent diagnosis with cerebral toxoplasmosis, and for coronary artery disease after two bypass operations. Concerns: He wants to decide for himself who learns of his HIV diagnosis, and when; He wants to keep coaching and playing tennis without putting his heart at risk. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Bictegravir 50 mg, emtricitabine 200 mg, and tenofovir alafenamide 25 mg, one tablet by mouth once daily; take two hours before or six hours after antacids, calcium, iron, or magnesiumOne tablet by mouth once dailyOral route1988-09-25activeS
Pyrimethamine 25 mg oral tablet, 200 mg once, then three tablets (75 mg) by mouth daily for six weeks; course completed before intakeThree tablets by mouth daily after a 200 mg loading doseOral route1988-09-11 to 1988-10-23completedS
Sulfadiazine 500 mg oral tablet, three tablets (1500 mg) by mouth every 6 hours for six weeks; course completed before intakeThree tablets by mouth every 6 hoursOral route1988-09-11 to 1988-10-23completedS
Leucovorin 10 mg oral tablet, two tablets (20 mg) by mouth daily with pyrimethamine; course completed before intakeTwo tablets by mouth dailyOral route1988-09-11 to 1988-10-23completedS
Sulfamethoxazole 800 mg and trimethoprim 160 mg (double strength), one tablet by mouth twice dailyOne tablet by mouth twice dailyOral route1988-10-23 to 1989-10-19completedS
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1979-07-31activeS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1979-08-01activeS
Ezetimibe 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route1989-01-12activeS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tabletOne tablet under the tongue every 5 minutes as needed for chest pain, up to 3 dosesSublingual route1979-08-01activeS

Procedures

ProcedureDatesStatusEvidence
Coronary artery bypass grafting, four grafts, after a myocardial infarction at age 361979-12-13 to 1979-12-13completedS
Repeat coronary artery bypass grafting, two grafts, for recurrent angina; blood transfusion given1983-06-15 to 1983-06-15completedS
MRI of the head with contrast: single ring-enhancing lesion in the left frontoparietal region with surrounding edema1988-09-08 to 1988-09-08completedS
Stereotactic biopsy of the left frontoparietal lesion: necrotizing inflammation with Toxoplasma gondii organisms; no lymphoma1988-09-10 to 1988-09-10completedS
12-lead electrocardiogram: sinus rhythm 72/min, old inferior Q waves, no acute ST change1989-01-12 to 1989-01-12completedS
Advance care planning conversation, about 20 minutes1989-08-17 to 1989-08-17completedS

Immunizations

DateVaccineStatusEvidence
1984-05-03Tdap vaccinecompletedS
1988-09-18Influenza vaccine, 1988-1989 season, given in the hospitalcompletedS
1989-01-12Pneumococcal conjugate vaccine PCV20completedS
1989-01-12Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS
1989-01-12Meningococcal conjugate vaccine MenACWY, dose 1 of 2completedS
1989-02-09Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS
1989-04-13Meningococcal conjugate vaccine MenACWY, dose 2 of 2completedS
1989-04-13Recombinant zoster vaccine, dose 1 of 2completedS
1989-08-17Recombinant zoster vaccine, dose 2 of 2completedS
1989-10-19Influenza vaccine, 1989-1990 seasoncompletedS
1989-10-19COVID-19 vaccine, 1989-1990 formulacompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
July 31, 1979Heart attack at age 36 while teaching tennis to young people, followed by quadruple coronary artery bypass surgeryD (CLM-0002)
1983Second (double) bypass operation for recurrent chest pain, with a blood transfusionD (CLM-0003)
1988Right-arm weakness from a left-sided brain mass, removed and found to be toxoplasmosis; HIV and AIDS diagnosed, believed to have been acquired from the transfusion during the 1983 operationD (CLM-0004, CLM-0005)

Family History

RelativeConditionAge at deathEvidence
motherDied at 27 of complications from surgery; atherosclerotic heart disease at an early age reportedD (CLM-0007)
fatherHeart attacks at 55 and 59; atherosclerotic heart disease at an early age reportedD (CLM-0007)

Health Concerns

ConcernStatusEvidence
He wants to decide for himself who learns of his HIV diagnosis, and whenactiveS
He wants to keep coaching and playing tennis without putting his heart at riskactiveS

Assessment

Most recent measures: HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection 0 on 1989-10-19; CD3+CD4+ (T4 helper) cells [#/volume] in Blood 318 on 1989-10-19; Leukocytes [#/volume] in Blood by Automated count 5 on 1989-10-19; Hemoglobin [Mass/volume] in Blood 14.1 on 1989-10-19; Platelets [#/volume] in Blood by Automated count 236 on 1989-10-19; Sodium [Moles/volume] in Serum or Plasma 140 on 1989-10-19; Potassium [Moles/volume] in Serum or Plasma 4.5 on 1989-10-19; Creatinine [Mass/volume] in Serum or Plasma 1.12 on 1989-10-19; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M 82 on 1989-10-19; Glucose [Mass/volume] in Serum or Plasma 91 on 1989-10-19; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 27 on 1989-04-13; Cholesterol [Mass/volume] in Serum or Plasma 118 on 1989-04-13; Cholesterol in HDL [Mass/volume] in Serum or Plasma 41 on 1989-04-13; Triglyceride [Mass/volume] in Serum or Plasma 125 on 1989-04-13; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 52 on 1989-04-13; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 1989-01-12; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 1989-07-13; Total score [AUDIT-C] 1 on 1989-08-17; Lipoprotein a [Mass/volume] in Serum or Plasma 24 on 1989-04-13; Hepatitis B virus surface Ab [Units/volume] in Serum 86 on 1989-04-13; Albumin/Creatinine [Mass Ratio] in Urine 12 on 1989-07-13; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1989-08-17 [S]

Strengths and supports: Supports: married, with a young child, and close friends; has told only a few people about his HIV diagnosis [S]

Problems

ProblemClinical statusVerificationCodeProvenance
HIV infection, diagnosed about four months before intake with a CD4 count of 58 cells/uL and cerebral toxoplasmosis (an AIDS-defining illness); on antiretroviral therapy since; synthetic modern episode linked to the documented transfusion-acquired infectionactiveconfirmed B20S — Synthetic modern coding of the documented HIV infection and AIDS diagnosis; B20 stays the code after an AIDS-defining illness, however well the infection is controlled.
Cerebral toxoplasmosis, single left-sided lesion with right-hand weakness, diagnosed by stereotactic biopsy; six weeks of acute treatment completed; weakness recovered; on maintenance therapyactiveconfirmed B58.2S — Synthetic modern coding of the documented 1988 toxoplasmosis; the modern diagnosis was by biopsy rather than removal of the mass.
Coronary artery disease after two bypass operations (quadruple, then double), no angina; synthetic modern episode linked to the documented 1942 and 1946 operationsactiveconfirmed I25.10S — Synthetic modern diagnosis; the history remains D.
Old myocardial infarction at age 36activeconfirmed I25.2S — Synthetic coded history of the documented 1979 heart attack.
Hyperlipidemia, on high-intensity statinactiveconfirmed E78.5S — Synthetic diagnosis; no cholesterol value from his lifetime is used.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1989-01-12HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection42{copies}/mLBelow 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detectedHighS
1989-01-12CD3+CD4+ (T4 helper) cells [#/volume] in Blood156/uL500-1500 /uLLowS
1989-01-12Leukocytes [#/volume] in Blood by Automated count4.210*3/uL4-11 10*3/uLNormalS
1989-01-12Hemoglobin [Mass/volume] in Blood13g/dL13.2-16.6 g/dLLowS
1989-01-12Platelets [#/volume] in Blood by Automated count19810*3/uL150-400 10*3/uLNormalS
1989-01-12Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1989-01-12Potassium [Moles/volume] in Serum or Plasma4.9mmol/L3.5-5.1 mmol/LNormalS
1989-01-12Creatinine [Mass/volume] in Serum or Plasma1.18mg/dL0.74-1.35 mg/dLNormalS
1989-01-12Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M78mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1989-01-12Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
1989-01-12Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma30U/L7-56 U/LNormalS
1989-01-12Cholesterol [Mass/volume] in Serum or Plasma158mg/dL<=199 mg/dLNormalS
1989-01-12Cholesterol in HDL [Mass/volume] in Serum or Plasma40mg/dL>=40 mg/dLNormalS
1989-01-12Triglyceride [Mass/volume] in Serum or Plasma150mg/dL<=149 mg/dLHighS
1989-01-12Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation88mg/dL<=99 mg/dLNormalS
1989-01-12Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS
1989-01-12Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
1989-01-12Total score [AUDIT-C]1{score}S
1989-02-09Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1989-02-09Potassium [Moles/volume] in Serum or Plasma4.8mmol/L3.5-5.1 mmol/LNormalS
1989-02-09Creatinine [Mass/volume] in Serum or Plasma1.16mg/dL0.74-1.35 mg/dLNormalS
1989-02-09Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M79mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1989-02-09Glucose [Mass/volume] in Serum or Plasma90mg/dL70-99 mg/dLNormalS
1989-04-13HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection0{copies}/mLBelow 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detectedNormalS
1989-04-13CD3+CD4+ (T4 helper) cells [#/volume] in Blood218/uL500-1500 /uLLowS
1989-04-13Leukocytes [#/volume] in Blood by Automated count4.610*3/uL4-11 10*3/uLNormalS
1989-04-13Hemoglobin [Mass/volume] in Blood13.6g/dL13.2-16.6 g/dLNormalS
1989-04-13Platelets [#/volume] in Blood by Automated count22410*3/uL150-400 10*3/uLNormalS
1989-04-13Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1989-04-13Potassium [Moles/volume] in Serum or Plasma4.7mmol/L3.5-5.1 mmol/LNormalS
1989-04-13Creatinine [Mass/volume] in Serum or Plasma1.15mg/dL0.74-1.35 mg/dLNormalS
1989-04-13Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M80mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1989-04-13Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
1989-04-13Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma27U/L7-56 U/LNormalS
1989-04-13Cholesterol [Mass/volume] in Serum or Plasma118mg/dL<=199 mg/dLNormalS
1989-04-13Cholesterol in HDL [Mass/volume] in Serum or Plasma41mg/dL>=40 mg/dLNormalS
1989-04-13Triglyceride [Mass/volume] in Serum or Plasma125mg/dL<=149 mg/dLNormalS
1989-04-13Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation52mg/dL<=99 mg/dLNormalS
1989-04-13Lipoprotein a [Mass/volume] in Serum or Plasma24mg/dL<=29 mg/dLNormalS
1989-04-13Hepatitis B virus surface Ab [Units/volume] in Serum86m[IU]/mL>=10 m[IU]/mLNormalS
1989-07-13HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection0{copies}/mLBelow 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detectedNormalS
1989-07-13CD3+CD4+ (T4 helper) cells [#/volume] in Blood262/uL500-1500 /uLLowS
1989-07-13Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1989-07-13Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
1989-07-13Creatinine [Mass/volume] in Serum or Plasma1.14mg/dL0.74-1.35 mg/dLNormalS
1989-07-13Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M80mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1989-07-13Glucose [Mass/volume] in Serum or Plasma93mg/dL70-99 mg/dLNormalS
1989-07-13Albumin/Creatinine [Mass Ratio] in Urine12mg/g<=29 mg/gNormalS
1989-07-13Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S
1989-08-17Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1989-08-17Total score [AUDIT-C]1{score}S
1989-10-19HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection0{copies}/mLBelow 20 copies/mL (limit of quantification); 0 means HIV-1 RNA not detectedNormalS
1989-10-19CD3+CD4+ (T4 helper) cells [#/volume] in Blood318/uL500-1500 /uLLowS
1989-10-19Leukocytes [#/volume] in Blood by Automated count510*3/uL4-11 10*3/uLNormalS
1989-10-19Hemoglobin [Mass/volume] in Blood14.1g/dL13.2-16.6 g/dLNormalS
1989-10-19Platelets [#/volume] in Blood by Automated count23610*3/uL150-400 10*3/uLNormalS
1989-10-19Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
1989-10-19Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
1989-10-19Creatinine [Mass/volume] in Serum or Plasma1.12mg/dL0.74-1.35 mg/dLNormalS
1989-10-19Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1984)/1.73 sq M82mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1989-10-19Glucose [Mass/volume] in Serum or Plasma91mg/dL70-99 mg/dLNormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
1989-01-12Body height185cmS
1989-01-12Body weight72kgS
1989-01-12Body mass index (BMI) [Ratio]21kg/m2S
1989-01-12Systolic blood pressure118mm[Hg]S
1989-01-12Diastolic blood pressure74mm[Hg]S
1989-01-12Heart rate72/minS
1989-01-12Respiratory rate14/minS
1989-01-12Body temperature36.7CelS
1989-01-12Oxygen saturation in Arterial blood by Pulse oximetry98%S
1989-02-09Body height185cmS
1989-02-09Body weight72.6kgS
1989-02-09Body mass index (BMI) [Ratio]21.2kg/m2S
1989-02-09Systolic blood pressure116mm[Hg]S
1989-02-09Diastolic blood pressure72mm[Hg]S
1989-02-09Heart rate70/minS
1989-02-09Respiratory rate14/minS
1989-02-09Body temperature36.6CelS
1989-02-09Oxygen saturation in Arterial blood by Pulse oximetry98%S
1989-04-13Body height185cmS
1989-04-13Body weight73.8kgS
1989-04-13Body mass index (BMI) [Ratio]21.6kg/m2S
1989-04-13Systolic blood pressure120mm[Hg]S
1989-04-13Diastolic blood pressure74mm[Hg]S
1989-04-13Heart rate68/minS
1989-04-13Respiratory rate14/minS
1989-04-13Body temperature36.7CelS
1989-04-13Oxygen saturation in Arterial blood by Pulse oximetry99%S
1989-07-13Body height185cmS
1989-07-13Body weight74.6kgS
1989-07-13Body mass index (BMI) [Ratio]21.8kg/m2S
1989-07-13Systolic blood pressure118mm[Hg]S
1989-07-13Diastolic blood pressure72mm[Hg]S
1989-07-13Heart rate66/minS
1989-07-13Respiratory rate14/minS
1989-07-13Body temperature36.6CelS
1989-07-13Oxygen saturation in Arterial blood by Pulse oximetry98%S
1989-10-19Body height185cmS
1989-10-19Body weight75kgS
1989-10-19Body mass index (BMI) [Ratio]21.9kg/m2S
1989-10-19Systolic blood pressure120mm[Hg]S
1989-10-19Diastolic blood pressure74mm[Hg]S
1989-10-19Heart rate66/minS
1989-10-19Respiratory rate14/minS
1989-10-19Body temperature36.6CelS
1989-10-19Oxygen saturation in Arterial blood by Pulse oximetry98%S
1989-08-17Body height185cmS
1989-08-17Body weight74.8kgS
1989-08-17Body mass index (BMI) [Ratio]21.9kg/m2S
1989-08-17Systolic blood pressure118mm[Hg]S
1989-08-17Diastolic blood pressure72mm[Hg]S
1989-08-17Heart rate64/minS
1989-08-17Respiratory rate14/minS
1989-08-17Body temperature36.6CelS
1989-08-17Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
1989-01-12Establishing primary care for HIV after a recent diagnosis with cerebral toxoplasmosis, and for coronary artery disease after two bypass operationsfinishedS
1989-02-09Four-week check of potassium and creatinine, second hepatitis B vaccine, and infectious diseases consultationfinishedS
1989-04-13Three-month HIV and lipid reviewfinishedS
1989-07-13Six-month HIV and coronary disease review with depression screeningfinishedS
1989-10-19Nine-month HIV review: decision to stop toxoplasmosis maintenance therapyfinishedS
1989-08-17Periodic adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Antiretroviral therapy with bictegravir, emtricitabine, and tenofovir alafenamide once daily, chosen for its high barrier to resistance and few interactions with his cardiac medicines; viral load and CD4 count every three monthscompletedGL-DHHS-ART, GL-IAS-ART-2024, GL-HIVMA-PC-2020S
Infectious diseases consultation to co-manage HIV: the regimen and its interactions, opportunistic-infection prophylaxis, the monitoring schedule, and vaccinescompletedGL-DHHS-ART, GL-DHHS-OIS
Toxoplasma maintenance therapy with trimethoprim-sulfamethoxazole double strength twice daily, which also prevents Pneumocystis pneumonia, until the CD4 count is above 200 for more than six months on suppressive therapy; blood count, potassium, and creatinine every three months while on itcompletedGL-DHHS-OIS
Secondary prevention of coronary disease after two bypass operations: aspirin, high-intensity atorvastatin with ezetimibe added for an LDL goal below 55 mg/dL, blood pressure below 130/80, a heart-healthy diet, regular exercise, and a written chest-pain plan with sublingual nitroglycerincompletedGL-CCD-2023, GL-CMID-2026S
Vaccines for adults with HIV: pneumococcal, hepatitis B with an antibody check afterwards, the two-dose meningococcal ACWY series, recombinant zoster, and seasonal influenza and COVID-19, with no live vaccines while the CD4 count is below 200completedGL-CDC-IMZ-HIV, GL-HIVMA-PC-2020S
Person-first, confidential care: he decides who learns of his diagnosis; support with disclosure if and when he chooses, peer support, and depression screening with the PHQ-9 at intake and six months and the PHQ-2 at the preventive visitcompletedGL-HIVMA-PC-2020, GL-USPSTF-DEP-2023, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
HIV-1 viral load not detected by the three-month visit1989-04-13completedViral load not detected (below 20 copies/mL) at three months, and at six and nine monthsS
CD4 count above 200 cells/uL for more than six months with an undetectable viral load, so that maintenance therapy can stop safely1989-10-19completedCD4 218 at three months, 262 at six months, and 318 at nine months; trimethoprim-sulfamethoxazole stoppedS
LDL cholesterol below 55 mg/dL by the three-month visit1989-04-13completedLDL cholesterol 52 mg/dL on atorvastatin and ezetimibeS
Hepatitis B vaccine series completed with a protective antibody level by the three-month visit1989-04-13completedHepatitis B surface antibody 86 mIU/mLS
Keep blood pressure below 130/80 mmHg1989-07-13completedBlood pressure 116 to 120 over 72 to 74 at every visitS

Functional Status

Mental Status